fbpx

Infertility and Immunology: Dr. Geneviève Genest


Can infertility be treated successfully? Why does recurring infertility happen? One out of six Canadian couples experience fertility problems. While many become parents thanks to artificial insemination and in vitro fertilization, the usual treatments don’t seem to work for some. Dr. Geneviève Genest, immunologist and researcher at the Montreal General Hospital (MUHC) is on a mission to find out why. Along the way, she is helping a majority of couples who visit her clinic –one that is unique in Canada- get pregnant and have the family the always dreamed of.

Annie DeMelt speaks with Dr. Genest about why the immune system matters in pregnancy; and how certain blood molecules, such as immunoglobulin, can be a game changer for some couples.

Annual Report

+ DOWNLOAD OUR REPORT

DOWNLOAD OUR REPORT
read
Helping Her Patients Become Mothers
Tuesday 6 March 2018
read
Research: Helping Our Patients Become Parents
Friday 15 September 2017
read
Private: Unraveling the Mysteries of the Immune System
Wednesday 11 October 2017
read
Celebrating Research and Philanthropy at the MGHF’s Impact & Innovation Evening  
Wednesday 30 October 2024
read
Dr. Ahmed Aoude’s Groundbreaking Surgeries and AI Research Save Lives
Friday 13 September 2024
read
Four Startups Selected for the MGH Foundation’s Impact Investment Program
Thursday 1 August 2024
read
The 45th Annual Golf Classic
Wednesday 19 June 2024
read
A Generous Donation from BMO to Advance Research in Mental Health, Trauma Care, and Thoracic Surgery
Wednesday 12 June 2024
read
Together, We Raised Over $180,000 for Mental Health at the Pharmaprix Run for Women!
Monday 10 June 2024
read
RI-MUHC Building Named in Honour of Dr. Phil Gold
Thursday 6 June 2024
read
The Future of Neurosurgery: How Neuro Navigation Helps Save Lives
Thursday 30 May 2024
read
The Montreal General Hospital Foundation has a brand new look!
Monday 6 May 2024
read
Honouring Margery Trenholme: The Librarian Who Left a Lasting Legacy of Generosity
Tuesday 2 April 2024